Sarah E. Holden

1.4k total citations
39 papers, 1.0k citations indexed

About

Sarah E. Holden is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Ophthalmology. According to data from OpenAlex, Sarah E. Holden has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 6 papers in Ophthalmology. Recurrent topics in Sarah E. Holden's work include Diabetes Treatment and Management (15 papers), Diabetes Management and Research (12 papers) and Metabolism, Diabetes, and Cancer (8 papers). Sarah E. Holden is often cited by papers focused on Diabetes Treatment and Management (15 papers), Diabetes Management and Research (12 papers) and Metabolism, Diabetes, and Cancer (8 papers). Sarah E. Holden collaborates with scholars based in United Kingdom, United States and Austria. Sarah E. Holden's co-authors include Craig J. Currie, Sara Jenkins‐Jones, Christopher Ll. Morgan, Jayanti Mukherjee, Chris D. Poole, Guntram Schernthaner, Julian Halcox, Christian Bannister, C. J. Currie and John R. Peters and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Journal of Endocrinology.

In The Last Decade

Sarah E. Holden

38 papers receiving 982 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah E. Holden United Kingdom	16	457	292	174	127	92	39	1.0k
Kyung Won Lee South Korea	21	130 0.3×	147 0.5×	309 1.8×	71 0.6×	40 0.4×	82	1.2k
Maria Cristina Monti Italy	19	169 0.4×	278 1.0×	77 0.4×	97 0.8×	59 0.6×	83	1.2k
Lluís Masmiquel Spain	17	167 0.4×	159 0.5×	110 0.6×	130 1.0×	28 0.3×	68	806
Karoline Schousboe Denmark	15	245 0.5×	147 0.5×	224 1.3×	90 0.7×	31 0.3×	26	1.2k
Carla Pelusi Italy	24	833 1.8×	308 1.1×	251 1.4×	163 1.3×	108 1.2×	53	2.4k
Shabnam Salimi United States	17	46 0.1×	210 0.7×	234 1.3×	52 0.4×	53 0.6×	32	1.2k
Paul Hardiman United Kingdom	27	484 1.1×	239 0.8×	79 0.5×	110 0.9×	95 1.0×	84	3.0k
Ronny Baber Germany	16	117 0.3×	144 0.5×	136 0.8×	80 0.6×	79 0.9×	56	811
M. Pertovaara Finland	22	96 0.2×	236 0.8×	499 2.9×	185 1.5×	125 1.4×	34	1.5k
R. T. Jung United Kingdom	17	411 0.9×	133 0.5×	317 1.8×	225 1.8×	37 0.4×	30	1.2k

Countries citing papers authored by Sarah E. Holden

Since Specialization

Citations

This map shows the geographic impact of Sarah E. Holden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Holden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Holden more than expected).

Fields of papers citing papers by Sarah E. Holden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Holden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Holden. The network helps show where Sarah E. Holden may publish in the future.

Co-authorship network of co-authors of Sarah E. Holden

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. Holden. A scholar is included among the top collaborators of Sarah E. Holden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. Holden. Sarah E. Holden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morgan, Christopher Ll., Sara Jenkins‐Jones, Sarah E. Holden, et al.. (2023). Real-world evidence from the first online healthcare analytics platform—Livingstone. Validation of its descriptive epidemiology module. SHILAP Revista de lepidopterología. 2(7). e0000310–e0000310. 1 indexed citations

Holden, Sarah E., Maged Habib, & Craig J. Currie. (2020). Retinal thickness fluctuations in patients receiving fluocinolone acetonide implant for diabetic macular edema. Current Medical Research and Opinion. 36(6). 959–965. 6 indexed citations

Birring, Surinder S., Sarah E. Holden, Sara Jenkins‐Jones, et al.. (2020). Healthcare utilization and cost associated with chronic cough in the United Kingdom: a retrospective observational study. 3822–3822. 3 indexed citations

Holden, Sarah E., Barry Kapik, Annette B. Beiderbeck, & Craig J. Currie. (2018). Comparison of data characterizing the clinical effectiveness of the fluocinolone intravitreal implant (ILUVIEN) in patients with diabetic macular edema from the real world, non-interventional ICE-UK study and the FAME randomized controlled trials. Current Medical Research and Opinion. 35(7). 1165–1176. 7 indexed citations

Morgan, Christopher Ll., Qing Qiao, Susan Grandy, et al.. (2018). Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study. Diabetes Therapy. 9(1). 269–283. 5 indexed citations

Jenkins‐Jones, Sara, John B. Porter, Martin J. Whitaker, et al.. (2018). Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia. European Journal of Endocrinology. 178(4). 309–320. 54 indexed citations

Currie, Craig J., Sarah E. Holden, Sara Jenkins‐Jones, et al.. (2017). Impact of differing glucose‐lowering regimens on the pattern of association between glucose control and survival. Diabetes Obesity and Metabolism. 20(4). 821–830. 5 indexed citations

Holden, Sarah E., Christopher Ll. Morgan, Qing Qiao, et al.. (2017). Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study. Diabetes Obesity and Metabolism. 19(8). 1097–1105. 4 indexed citations

Currie, Craig J., Sarah E. Holden, & David R. Owens. (2017). Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 µg intravitreal implant for diabetic macular edema. Current Medical Research and Opinion. 33(sup2). 33–43. 12 indexed citations

10.

Currie, Craig J., Sarah E. Holden, Ellen Berni, & David R. Owens. (2017). Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes. Current Medical Research and Opinion. 33(sup2). 19–31. 12 indexed citations

11.

Holden, Sarah E., Sara Jenkins‐Jones, & Craig J. Currie. (2016). Association between Insulin Monotherapy versus Insulin plus Metformin and the Risk of All-Cause Mortality and Other Serious Outcomes: A Retrospective Cohort Study. PLoS ONE. 11(5). e0153594–e0153594. 22 indexed citations

12.

Holden, Sarah E., Sara Jenkins‐Jones, Christopher Ll. Morgan, Guntram Schernthaner, & Craig J. Currie. (2014). Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: Dose-response association with all-cause mortality, cardiovascular events, and incident cancer. Value in Health. 17(3). A240–A240. 3 indexed citations

13.

Holden, Sarah E. & Craig J. Currie. (2014). The impact of concomitant metformin on mortality and other serious outcomes in people with type 2 diabetes treated with insulin. Value in Health. 17(3). A241–A241. 1 indexed citations

14.

Bannister, Christian, Sarah E. Holden, Sara Jenkins‐Jones, et al.. (2014). Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non‐diabetic controls. Diabetes Obesity and Metabolism. 16(11). 1165–1173. 255 indexed citations

15.

Mukherjee, Jayanti, et al.. (2014). Association between first‐line monotherapy with sulphonylurea versus metformin and risk of all‐cause mortality and cardiovascular events: a retrospective, observational study. Diabetes Obesity and Metabolism. 16(10). 957–962. 54 indexed citations

16.

Holden, Sarah E., Sara Jenkins‐Jones, Chris D. Poole, et al.. (2013). The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child and Adolescent Psychiatry and Mental Health. 7(1). 34–34. 68 indexed citations

17.

Poole, Chris D., et al.. (2012). PMS19 Impact of Disease Severity on the Total, Health-Related, Financial Costs of Treatment of People with Rheumatoid Arthritis in the United Kingdom. Value in Health. 15(4). A36–A37. 1 indexed citations

18.

Holden, Sarah E., Chris D. Poole, Christopher Ll. Morgan, & Craig J. Currie. (2011). Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin. BMJ Open. 1(2). e000258–e000258. 48 indexed citations

19.

Hall, Pauline & Sarah E. Holden. (2008). Association of Psychosocial and Demographic Factors With Postpartum Negative Thoughts and Appraisals. The Journal of Perinatal & Neonatal Nursing. 22(4). 275–281. 6 indexed citations

20.

Holden, Sarah E., et al.. (2004). The effectiveness of community-based animal health workers, for the poor, for communities and for public safety. Revue Scientifique et Technique de l OIE. 23(1). 253–276. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact